References
- Kim H, Mazza J. Asthma. Allergy Asthma Clin Immunol 2011; 7(Suppl 1):S2.
- National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung, and Blood Institute. NIH Publication 07–4051. 2007. Available at: http://www.ncbi.nlm.nih.gov/books/NBK7232/. Accessed June 14, 2012.
- Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FizGerald M, Gibson P, Ohta K, O’Byrne P, Pdersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31:143–178.
- American Lung Association. Trends in asthma morbidity and mortality. July, 2011. Available at: http://www.lung.org/finding-cures/our-research/trend-reports/asthma-trend-report.pdf. Accessed June 14, 2012.
- Asthma in the US. Growing every year. Available at: http://www.cdc.gov/VitalSigns/Asthma/. Accessed February 6, 2012.
- United States Environmental Protection Agency. Asthma facts. 2011; EPA-402-F-04-019. Available at: http://www.epa.gov/asthma/pdfs/asthma_fact_sheet_en.pdf. Accessed June 14, 2012.
- Asthma statistics. Available at: http://www.aaaai.org/about-the-aaaai/newsroom/asthma-statistics.aspx. Accessed February 6, 2012.
- Sullivan PW, Ghushchyan VH, Slejko JF, Belozeroff V, Globe DR, Lin S-L. The burden of adult asthma in the United States: Evidence from the Medical Expenditure Panel Survey. J Allergy Clin Immunol 2011; 127:363–369.
- Chen H, Gould MK, Blanc PD, Miller DP, Kamath TV, Lee JH, Sullivan SD. Asthma control, severity, and quality of life: Quantifying the effect of uncontrolled disease. J Allergy Clin Immunol 2007; 120:396–402.
- Lee-Wong M, Chou V, Ogawa Y. Formoterol fumarate inhalation powder vs albuterol nebulizer for the treatment of asthma in the acute care setting. Ann Allergy Asthma Immunol 2008; 100:146–152.
- Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2006(2):CD000052. April 19; doi: 10.1002/14651858.CD000052.pub2.
- Rubin BK. What does it mean when a patient says, My asthma medication is not working?. Chest 2004; 126:972–981.
- Schultz RK. Drug delivery characteristics of metered-dose inhalers. J Allergy Clin Immunol 1995; 96:284–287.
- Sander N, Fusco-Walkert SJ, Harder JM, Chipps BE. Dose counting and the use of pressurized metered-dose inhalers: Running on empty. Ann Allergy Asthma Immunol 2006; 97:34–38.
- Ogren RA, Baldwin JL, Simon RA. How patients determine when to replace their metered-dose inhalers. Ann Allergy Asthma Immunol 1995; 75:485–489.
- Guidance for Industry: Integration of dose-counting mechanisms into MDI drug products. Available at: http://www.fda.gov/cder/guidance/index.htm. Accessed June 14, 2012.
- Rubin BK, Durotoye L. How do patients determine that their metered-dose inhaler is empty? Chest 2004; 126:1134–1137.
- Hess DR. Aerosol delivery devices in the treatment of asthma. Respir Care 2008; 53:699–723.
- Guidance for Industry. Metered dose inhaler (MDI) and dry powder inhaler (DPI) drug products. Chemistry, manufacturing and controls. Available at: http://www.fda.gov/downloads/Drugs/Guidances/ucm070573.pdf.Accessed March 12, 2013.
- Rickenbach MA, Julious SA. Assessing fullness of asthma patients’ aerosol inhalers. Br J Gen Pract 1994; 44:317–318.
- Holt S, Holt A, Weatherall M, Masoli M, Beasley R. Metered dose inhalers: A need for dose counters. Respirology 2005; 10:105–106.
- Wasserman RL, Sheth K, Lincourt WR, Locantore NW, Carranza-Rosenzweig J, Crim C. Real-world assessment of a metered-dose inhaler with integrated dose counter. Allergy Asthma Proc 2006; 27:486–492.
- Sheth K, Wasserman RL, Lincourt WR, Locantore NW, Carranza-Rosenzweig J, Crim C. Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfaction. Int J Clin Pract 2006; 60: 1218–1224.
- LaForce C, Weinstein C, Nathan RA, Weinstein SF, Staudinger H, Meltzer EO. Patient satisfaction with a pressurized metered-dose inhaler with an integrated dose counter containing a fixed-dose mometasone furoate/formoterol combination. J Asthma 2011; 48:625–631.
- Pereira ED, Cavalcante AG, Pereira EN, Lucas P, Holanda MA. Asthma control and quality of life in patients with moderate or severe asthma. J Bras Pneumol 2011; 37:705–711.
- ProAir® HFA (albuterol sulfate) Inhalation Aerosol prescribing information. Teva Respiratory, LLC, Horsham, PA. Rev 03/2012.
- Ventolin® HFA (albuterol sulfate) prescribing information. GlaxoSmithKline, Research Triangle Park, NC. Rev 10/2012.
- National Heart, Lung, and Blood Institute. Chartbook on Cardiovascular, Lung and Blood Diseases. Available at: http://www.nhlbi.nih.gov/resources/docs/2009_ChartBook.pdf. Accessed February 1, 2012.
- Barnett SB, Nurmagambetov TA. Costs of asthma in the United States: 2002–2007. J Allergy Clin Immunol 2011; 127:145–152.